The current study examined the long-term effects of neonatal amygdala (Neo-A) lesions on brain corticotropin-releasing factor (CRF) systems and hypothalamic-pituitary-adrenal (HPA) axis function of male and female prepubertal rhesus monkeys. At 12-months-old, CSF levels of CRF were measured and HPA axis activity was characterized by examining diurnal cortisol rhythm and response to pharmacological challenges. Compared with controls, Neo-A animals showed higher cortisol secretion throughout the day, and Neo-A females also showed higher CRF levels. Hypersecretion of basal cortisol, in conjunction with blunted pituitary-adrenal responses to CRF challenge, suggest HPA axis hyperactivity caused by increased CRF hypothalamic drive leading to downregulation of pituitary CRF receptors in Neo-A animals. This interpretation is supported by the increased CRF CSF levels, suggesting that Neo-A damage resulted in central CRF systems overactivity. Neo-A animals also exhibited enhanced glucocorticoid negative feedback, as reflected by an exaggerated cortisol suppression following dexamethasone administration, indicating an additional effect on glucocorticoid receptor (GR) function. Together these data demonstrate that early amygdala damage alters the typical development of the primate HPA axis resulting in increased rather than decreased activity, presumably via alterations in central CRF and GR systems in neural structures that control its activity. Thus, in contrast to evidence that the amygdala stimulates both CRF and HPA axis systems in the adult, our data suggest an opposite, inhibitory role of the amygdala on the HPA axis during early development, which fits with emerging literature on "developmental switches" in amygdala function and connectivity with other brain areas.
Introduction
The hypothalamic-pituitary-adrenal (HPA) axis plays a critical role in homeostasis, with a basal circadian secretory rhythm characterized by a peak in cortisol secretion upon awakening, and a decline across the day with a trough at night (Weitzman et al., 1971; Keller-Wood and Dallman, 1984) . Superimposed upon this basal rhythm is the reactive HPA stress response, critical to respond to threats. The amygdala plays a crucial role coordinating behavioral, autonomic, and neuroendocrine stress responses, via mostly excitatory influences on the hypothalamus and brainstem (Aggleton, 2000) . It stimulates the HPA axis through indirect projections to the hypothalamic paraventricular nucleus (PVN), including a disinhibitory pathway via the bed nucleus of the stria terminalis (Feldman et al., 1990; Herman et al., 2003 Freese and Amaral, 2009) . PVN stimulation releases corticotropin-releasing factor (CRF) into the portal vasculature, which binds to CRF receptors in the anterior pituitary stimulating the release of adrenocorticotrophic hormone (ACTH), which stimulates the synthesis and release of glucocorticoids by the adrenals (Ulrich-Lai and Herman, 2009 ). Glucocorticoids inhibit their own release via negative feedback through binding to glucocorticoid receptors (GRs) in the pituitary, PVN, and extrahypothalamic brain regions (Myers et al., 2012) .
The amygdala's excitatory influence on the HPA axis stress response has been primarily demonstrated in adult animals, with electrical stimulation increasing secretion of glucocorticoids (Mason, 1959; Redgate and Fahringer, 1973; Ehle et al., 1977) and lesions resulting in blunted HPA axis stress responses (Beaulieu et al., 1986; Feldman et al., 1994; Kalin et al., 2004; Machado and Bachevalier, 2008 ). Yet, its influence on HPA axis basal rhythm and negative feedback, particularly during development, has been less studied with scarce rodent studies suggesting a stimulatory role on basal HPA activity (Allen and Allen, 1975; Regev et al., 2012) and no effects reported following adult primate lesions (Norman and Spies, 1981; Sapolsky et al., 1991; Kalin et al., 2004; Machado and Bachevalier, 2008) , or neonatal amygdalectomy (Goursaud et al., 2006) . The amygdala's role on central CRF systems has also been poorly documented in primates, with scarce studies reporting reduced CRF levels in CSF and HPA axis stress reactivity following adult bilateral lesions of the central nucleus (CeA; Kalin et al., 2004) . Thus, there are significant gaps in our understanding of the role of the primate amygdala on the development of the HPA axis and central CRF systems.
Given that developmental neuropsychiatric disorders, such as Autism spectrum disorder, schizophrenia, and mood disorders exhibit both aberrant amygdala development and dysregulation of CRF and HPA functions (Schumann et al., 2011; , we investigated the effects of neonatal amygdala lesions on macaque CRF/HPA axis development. We previously reported altered diurnal cortisol rhythm in infancy (Raper et al., 2013a) and heightened cortisol stress response as juveniles (Raper et al., 2013b ). Here we studied whether the effects of neonatal amygdala lesions on diurnal cortisol persist during the juvenile period, as well as the neurobiological mechanisms that underlie higher-stress reactivity, using central CRF measures and pharmacological challenges to examine pituitary-adrenal and negative-feedback functions.
Materials and Methods
Subjects. All animals were raised by middle-ranking mothers and lived in large social groups of 50 -75 adult females with their juvenile and infant offspring and two breeder males (38 ϫ 39 m indoor/outdoor compounds) at the Yerkes National Primate Research Center (YNPRC) Field Station (Lawrenceville, GA), Emory University. Of the 31 juvenile rhesus monkeys (Macaca mulatta) that were included in the original longitudinal developmental study (Raper et al., 2013a,b) , 11 could not be included in the current study due to illnesses or injuries, reducing the sample size to 20 animals for the current studies. At 24.8 Ϯ 1.2 d of age, nine animals (6 males, 3 females) received neonatal neurotoxic lesions of the amygdala (Neo-A) and eight animals (3 males, 5 females) received sham operations (Neo-C). In addition, three animals (2 males, 1 female) received the same experimental manipulation given to the Neo-C except for the neuroimaging and surgical procedures and were labeled "behavioral controls" (Neo-BC). Although briefly summarized below, procedures for neuroimaging, surgery, estimation of lesion extent, and mother-infant separations/reunion for surgery and returned to the social group after recovery were described in detail in previous reports (Raper et al., 2013a,b) and were performed at the YNPRC Main Station (Atlanta, GA). For the current study, HPA axis neuroendocrine function, as well as CRF concentrations in CSF, were assessed at 12 months of age. The Animal Care and Use Committee of Emory University approved all procedures, which were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals.
Imaging procedures. On the day of surgery, the infants were removed from their mother, sedated with ketamine hydrochloride (1 mg/kg) and maintained with isoflurane (1-2% to effect). Their head was secured in a nonferromagnetic stereotaxic apparatus, and two MRI sequences were acquired using a Siemens 3.0T/90 cm whole-body scanner and a 3 inch circular surface coil. A high resolution T1-weighted scan [spin-echo sequence, echo time (TE) ϭ 11 ms, repetition time (TR) ϭ 450 ms, contiguous 1 mm section, 12 cm field-of-view (FOV), 256 ϫ 256 matrix] obtained in the coronal plane was used to determine the coordinates of injection sites in the amygdala. Three additional fluid attenuated inversion recovery (FLAIR) scans (3D T2-weighted fast spoiled gradient-echo sequences, TE ϭ 2.6 ms, TR ϭ 10.2 ms, 25 flip angle, 12 cm FOV, 256 ϫ 256 matrix) were obtained in the coronal plane at 3.0 mm (each offset of 1 mm posteriorly) throughout the brain. These two MRI sequences were repeated 7-10 d after the surgical procedure for Neo-A animals to verify lesion site and extent, whereas Neo-C and Neo-BC animals were just separated from their mothers and placed in an isolette incubator for the same amount of time.
Surgical procedure. All surgical procedures were performed under aseptic conditions, an intravenous drip (0.45% dextrose/0.9% NaCl) was placed to maintain normal hydration, and vital signs (heart rate, respirations, blood pressure, expired CO 2 ) were monitored throughout the surgery. Nolvasan solution was used to disinfect the scalp and a local anesthetic (Bupivacaine 0.25% concentration, 1.5 ml) was injected subcutaneously along the midline to reduce the pain during skin incision. After the skin and underlying connective tissue were gently displaced laterally, two small craniotomies were made in front of bregma and above the amygdala, and the dura was cut and retracted to expose the brain.
Animals in group Neo-A received injections of ibotenic acid (pH 7.4, 10 mg/ml concentration) in six to eight sites within the center of the amygdala using 10 l Hamilton syringes. Needles were lowered simultaneously in both hemispheres and a total of 0.6 -0.8 l of ibotenic acid was manually injected at a rate of 0.2 l/min. After each injection, a 3 min waiting period was allotted to minimize neurotoxin spread during needle retractions. Neo-C animals received the same surgical procedures, however, no needles were lowered to avoid the potential risk of brain hemorrhage, and no injections were given.
At the completion of the surgical procedures, the dura was closed with silk sutures, the bone opening was covered with Surgicel NU-KNIT (absorbable hemostat), and connective tissues and skin were closed. The animal was removed from anesthesia, and placed in a temperaturecontrolled incubator ventilated with oxygen until full recovery from anesthesia. All animals received banamine (1 mg/kg for 3 d), dexamethasone (0.5 mg/kg for 3 d), and antibiotic (rocephin, 25 mg/kg for 7 d) after surgery to prevent pain, edema, and infection, respectively.
The Neo-BC animals were an additional control group, that did not receive the neuroimaging and surgical procedures but all other manipulations were similar to the other two groups, including maternal separation, sedation (ketamine hydrochloride, 1 mg/kg), shaving of head and scalp disinfection with Nolvasan Solution, and "postsurgery" medication treatments.
Mother-infant reunions and cross-fostering. The day after surgery, the infants were returned to their mothers and monitored constantly via a secure internet web camera. Most mothers (17 of 20 mothers) immediately retrieved their infants and the infants were observed nursing on the mother that same day. In a few cases, however, infants demonstrated difficulty nursing during the first reunion and the mother-infant pairs had to be separated overnight for a few days to monitor nutrition until the infant was able to nurse on the mother adequately.
In three cases, the mother-infant reunions were unsuccessful despite repeated attempts and in two cases the infants were adopted and raised by another adult female that already had an infant that birth season (Neo-A female and Neo-C male). In one case, an amygdalectomized male, was successfully cross-fostered to a mother that had recently lost her infant.
Mother-infant pairs were reintroduced back into their social groups using a staged introduction procedure. All introductions were monitored closely by researchers and were without incident.
Lesion verification. Estimation of the extent of intended and unintended damage for Neo-A animals was made using presurgical and postsurgical MR images (Málková et al., 2001; Nemanic et al., 2002) . The high-resolution T1 images were used to help identify the borders of each structure and lower-resolution FLAIR images were used to identify extent of hypersignals, which were then plotted onto corresponding coronal drawings from a normalized infant rhesus monkey brain (J. Bachevalier, unpublished atlas) using Adobe Photoshop software. Drawings were imported into image analysis program ImageJ (version 1.44) to measure the surface area (in pixels squared) containing hypersignals in the amygdala and in all surrounding structures (entorhinal and perirhinal cortex, and hippocampus). Surface areas measured and the slice thickness (i.e., 1 mm) were used to obtain an estimate of volume, and the volume of damage for each structure was then divided by the normal volume of that structure (obtained from the template brain in the same manner) and multiplied by 100 to estimate a percentage of the total damage volume.
CSF collection for CRF measures. When the animals reached 12 months of age, a single CSF sample was collected on each subject at sunrise, to match the diurnal timing of HPA axis assessments. Animals were trained to quickly separate from their social group using previously described methods (Sanchez et al., 2010; Raper et al., 2013a,b) . Once separated from the social group, animals were immediately anesthetized with Telazol (5 mg/kg, i.m.); the cervical spinal area was shaved, and disinfected with antiseptic solution (betadine) and alcohol. The CSF sample was obtained as soon as possible following anesthesia induction, and within 15 min from the initial group disturbance. CSF samples were collected from the cisterna magna drawn into a sterile 23-gauge, bevel-tipped needle by pressure difference and collected by gravity Sanchez et al., 2007) . CSF samples were immediately frozen on dry ice and stored at Ϫ80°C until assayed.
HPA axis assessments. At the same age (12 months), a thorough evaluation of long-term effects of neonatal amygdala damage on different aspects of HPA axis function was performed: basal, pituitary-adrenal activity, and glucocorticoid negative feedback. A separate report of stress hyper-reactivity was already published for these amygdalectomized animals at this same age (Raper et al., 2013b) .
HPA axis basal activity. Diurnal cortisol secretory rhythm was examined by basal blood samples collected at sunrise, mid-day, and sunset following published protocols (Sanchez et al., 2010; Raper et al., 2013a,b) . Briefly, because the animals live outdoors under natural lighting conditions, daylight time was used instead of clock time, and sunrise and sunset times were obtained from the US Naval Observatory (http://aa. usno.navy.mil/data/docs/RS_OneYear.php). Animals were trained to quickly separate from their social group for blood sample collection from the saphenous vein (unanesthetized) within 10 min of initial group disturbance, when experimenters first entered the social group. Blood samples were collected in prechilled 2 ml tubes containing EDTA (3.6 mg) and immediately placed on ice. Samples were centrifuged at 3000 rpm for 15 min in a refrigerated centrifuge (at 4°C). Plasma was stored at Ϫ80°C until assayed.
Pituitary-adrenal function. To assess the functionality of the pituitaryadrenal system, all animals received intravenous injections of either CRF, ACTH, or vehicle (saline) following a counterbalanced design for drug order and with a minimum interval between drug treatments of 1 week. The CRF, ACTH, and corresponding vehicle control intravenous challenges were performed following previously published protocols (Sanchez et al., 2010) , and under anesthesia to ensure that animals did not undergo stress-induced HPA axis activations due to repeated handling and venipuncture procedures. Therefore, the results reflect the activation of pituitary-adrenal receptors by the exogenous drugs and the potential effect of the anesthetic was controlled for by the inclusion of the vehicle control intravenous condition in the statistical analyses. Briefly, animals were accessed at sunrise (as described above for the diurnal cortisol assessment), before feeding or other routine care procedures to avoid both meal-or arousal-induced HPA axis activations. Once animals were separated from their social group a baseline blood sample (0 min) was taken by saphenous venipuncture within 10 min from disturbance, and subjects were immediately anesthetized (5 mg telazol/kg, i.m.). An intravenous bolus of r/h CRH (50 g/kg), ACTH (1 g/kg), or a vehicle solution (10 mM acetic acid/sterile 0.9% saline) was administered into the saphenous vein opposite to that used to draw blood from the animal, and additional blood samples were collected from the femoral vein at 15, 30, and 45 min after the injection. Blood samples were collected, processed, and stored as described above for the diurnal samples.
Glucocorticoid negative feedback. Animals were given an intramuscular injection of dexamethasone sodium phosphate (0.25 mg/kg) at night, 10 h before sunrise. The day after the dexamethasone injection, blood samples were collected at sunrise to examine the suppression of the early morning cortisol peak secretion and again at mid-day to examine the escape from dexamethasone suppression (ϳ16 h after injection). The sunrise and mid-day samples collected after dexamethasone suppression were statistically compared with the diurnal cortisol samples collected at the same times of the day.
CRF and cortisol assays. CSF samples were assayed for CRF levels by Dr Patrick Roseboom at the University of Wisconsin (Madison, WI). CSF CRF concentrations were measured using an antibody (rC68-5/31/83 bleed) generously provided by Dr Wylie Vale (Salk Institute for Biological Studies, La Jolla, CA). Briefly, the CSF was incubated for 72 h in the presence of the antibody, followed by a 48 h incubation with [ 125 ITyr 0 ]r,hCRH (PerkinElmer). The final dilution of the antibody was 1:1,000,000. Following the addition of normal rabbit serum (Bachem) as a carrier, the antigen-antibody complex was pelleted using goat antirabbit gamma globulin (Bachem) at 1700 ϫ g for 20 min. The supernatant was removed by aspiration and the radioactivity remaining in the pellet was counted in a gamma counter (PerkinElmer). The amount of CRF in the sample was determined using a standard curve ranging from 3.91 to 1000 pg/ml of rat/human, CRF (Sigma-Aldrich). All except three samples were assayed in triplicate with three samples assayed in duplicate due to low sample volume. All samples were processed together in a single CRF assay.
All plasma assays were performed by the YNPRC Biomarker Core Laboratory. Plasma samples for diurnal rhythm, CRF/ACTH/vehicle challenges, and dexamethasone suppression tests were assayed for cortisol. Concentrations of cortisol were assayed in duplicate by radioimmunoassay using commercially available kits (DSL kit, Diagnostic Systems Laboratories). The sensitivity of the DSL assay was 1.25 g/dl and intraand interassay coefficients of variation in each assay were Ͻ10%.
Statistical analyses. Before examining the effects of neonatal amygdala lesions on our measures, we first performed a preliminary analysis to statistically compare the two subgroups of control animals [i.e., behavioral controls (Neo-BC) and the sham-operated controls (Neo-C)] using repeated-measures ANOVA (control group ϫ time). Because no significant subgroup (or interaction) effects were found on any of the measures collected, data from both groups were combined to create a single control group referred to as Neo-C for all subsequent analyses. Thus, 20 subjects were included in the study (Neo-C: 5 males, 6 females; Neo-A: 6 males, 3 females).
A CSF sample could not be obtained from one Neo-C female within the 15 min limit and was dropped from analyses. Thus, 19 subjects were included in the final mixed-model ANOVA analysis of CRF levels in CSF (Neo-C: 5 males, 5 females; Neo-A: 6 males, 3 females), with group (Neo-A, Neo-C) and sex (male, female) as fixed factors.
All 20 subjects were included in the analysis of diurnal cortisol rhythm. A preliminary Hierarchical Linear Model (HLM) Regression analysis was performed to rule out effects of "time from disturbance" until collection of blood samples on basal cortisol levels, following previously published protocols (Raper et al., 2013a) . Because variance in basal cortisol levels were not significantly explained by the latency to collect the sample (R 2 ϭ 0.15, F (1,17) ϭ 1.59, p ϭ 0.23), "time-to-collection" was not used as a covariate in subsequent analyses of group differences in diurnal cortisol. Diurnal cortisol rhythm was analyzed using a repeated-measures ANOVA with group (Neo-A, Neo-C) and sex (male, female) as fixed factors and time of day (sunrise, mid-day, sunset) as the repeated measure.
One Neo-C female was excluded from the CRF/ACTH/vehicle challenges analyses due to illness (unrelated to the experiment). Another Neo-C female was excluded from the CRF challenge analyses because of incomplete injection of the neuropeptide. Therefore, 18 subjects were included in the final analyses for the CRF/vehicle challenge analyses (Neo-C: 5 males, 4 females; Neo-A: 6 males, 3 females) and 19 subjects were included in the final ACTH/vehicle analyses (Neo-C: 5 males, 5 females; Neo-A: 6 males, 3 females). Area under the curve with respect to increase (AUCi), which indicates the change in hormones secretions across time with respect to a baseline value, was used to measure the accumulative change in cortisol secretion in response to either CRF, ACTH, or vehicle injections, from baseline and over time (0, 15, 30, and 45 min postinjection; Pruessner et al., 2003) . Mix-design ANOVA with drug (vehicle vs ACTH-or CRF-), group (Neo-A, Neo-C), and sex (male, female) as fixed factors was used to analyze cortisol AUCi responses.
All 20 subjects were included in the analysis of cortisol suppression following dexamethasone injection. A preliminary HLM Regression analysis was conducted to rule out effects of time from disturbance until collection of the blood sample on dexamethasone-induced cortisol suppression, following previously published protocols (Raper et al., 2013a) . Because a significant amount of variance in cortisol levels after dexamethasone suppression was explained by the amount of time it took to collect the sample (R 2 ϭ 0.35, F (1,17) ϭ 6.33, p ϭ 0.009), time-to-collection was used as a covariate in subsequent analyses of group differences in dexamethasone suppression. Repeated-measures ANOVA included group (Neo-A, Neo-C), sex (male, female), and drug (diurnal/nondrug, dexamethasone) as the fixed factors, time of day (sunrise, mid-day) as the repeating measure, and time to collect the sample as a covariate. We also calculated the escape from dexamethasone suppression as the difference score between the mid-day and sunrise cortisol levels after dexamethasone suppression. This difference score was analyzed using ANCOVA with group (Neo-A, Neo-C) and sex (male, female) as fixed factors and time to collect the sample as a covariate.
Finally, the potential relationship between CRF levels in CSF, AUCi cortisol response to an intravenous CRF challenge, and extent of amygdala damage was investigated using a Pearson product correlation. Two animals were excluded from the analysis because either their CRF levels were not obtained (see above: analysis of CRF in CSF) or because they did not receive the full intravenous CRF injection (see above: intravenous CRF challenge analysis); thus a total of 18 animals were included in the correlation analyses.
Results

Lesion extent
Estimated bilateral damage to the amygdala, averaged 83.9% across both hemispheres (Table 1) , but varied from case to case. Thus, substantial bilateral damage to the amygdala in both hemispheres was found in seven cases, averaging 88.5 and 91.5% on the right and left, respectively. Two other cases had either moderate bilateral damage (Neo-A-F5: right 61.6%, left 58.4%) or more asymmetrical amygdala damage (Neo-A-M4: right 50.5%, left 84.9%). Unintended damage to surrounding structures was negligible in eight cases, and only one case had moderate damage to the tail of the putamen (Neo-A-F5). 
CSF concentrations of CRF
There was a significant group ϫ sex interaction for CRF concentrations (F (1,19) ϭ 6.5, p ϭ 0.022, 2 ; Fig. 2A) , with Neo-A females showing higher levels of CRF in CSF compared with Neo-A males and Neo-C animals of both sexes. These results suggest that neonatal amygdala lesions result in central CRF hypersecretion at least in females.
HPA axis assessments
Basal rhythm Both amygdala-lesioned and control groups exhibited a significant decline in cortisol secretion across the day (time of day: F (2,32) ϭ 54.21, p Ͻ 0.001, 2 ϭ 0.77; Fig. 3 ), which was linear (repeated contrasts: sunrise vs mid-day F (1,16) ϭ 31.7, p Ͻ 0.001, 2 ϭ 0.67; mid-day vs sunset F (1,16) ϭ 27.74, p Ͻ 0.001, 2 ϭ 0.63) and followed the species-typical adult-like pattern (Sánchez et al., 2005; Barrett et al., 2009) . However, despite similar patterns of daytime cortisol decline, Neo-A animals had significantly higher cortisol secretion compared with Neo-C animals throughout the day (group: F (1,16) ϭ 4.78, p ϭ 0.044, 2 ϭ 0.23) and this hypersecretion of cortisol did not differ by sex (sex: F (1,16) ϭ 0.92, p ϭ 0.35, 2 ϭ 0.06).
Pituitary-adrenal function (CRF and ACTH i.v. administration)
As shown in Figure 4A , after the ACTH challenge, both groups responded with a significantly increased cortisol compared with a saline injection (drug: F (1,38) ϭ 102.2, p Ͻ 0.001, 2 ϭ 0.77) and there was no difference between groups or sexes, or significant interactions. Exogenous administration of CRF resulted in a significant increase in cortisol in both groups compared with saline (drug: F (1,36) ϭ 28.4, p Ͻ 0.001, 2 ϭ 0.50), yet the response was blunted in Neo-A animals compared with controls (group: F (1,36) ϭ 5.42, p ϭ 0.027, 2 ϭ 0.16; Fig. 4B ). There was a significant positive relationship between CRF levels in CSF and AUCi cortisol response to exogenous administration of CRF (r (18) ϭ 0.45, p ϭ 0.03; Fig. 2B ). There was no relationship between the extent of amygdala damage and either CRF levels or AUCi cortisol response to CRF injection.
Last, glucocorticoid negative feedback was examined using the dexamethasone suppression test. As shown in Figure 3 , dexamethasone administration significantly suppressed cortisol levels at sunrise, 10 h after its administration in both groups, and all animals escaped the glucocorticoid negative feedback by mid-day (drug ϫ time: F (1,30) ϭ 43.5, p Ͻ 0.001, 2 ϭ 0.59). Nevertheless, neonatal amygdalectomy altered the effect of dexamethasone suppression (drug ϫ group: F (1,30) ϭ 4.91, p ϭ 0.035, 2 ϭ 0.14) with Neo-C animals (M ϭ 7.92 Ϯ 1.4 g/dl of cortisol) exhibiting a significantly greater escape from dexamethasone suppression than did Neo-A animals (M ϭ 2.52 Ϯ 1.6 g/dl of cortisol; group: F (1,20) ϭ 6.09, p ϭ 0.026, 2 ϭ 0.29). Therefore, despite basal HPA hyperactivity, Neo-A animals show greater glucocorticoid negative feedback than controls.
Discussion
The present study provides evidence that neonatal amygdala damage alters the normal development of central CRF systems and HPA axis function, leading to long-term effects in prepubertal juvenile monkeys (see Fig. 5 for summary) . In contrast to our initial predictions based on adult amygdala lesions, Neo-A animals secreted higher cortisol than controls throughout the day, suggesting that the increased basal HPA activity reported in these animals during infancy (Raper et al., 2013a) persists throughout the juvenile period and parallels their increased stress-induced cortisol reactivity (Raper et al., 2013b) . Neonatal lesions also resulted in blunted cortisol responses to CRF administration, indicating downregulation of pituitary CRF receptors as a consequence of hypothalamic CRF hyperactivity. This interpretation is supported, at least in Neo-A females, by their elevated CSF CRF levels. Last, Neo-A animals exhibited an exaggerated cortisol dexamethasone suppression, suggesting increased glucocorticoid negative feedback. Altogether, these results show that early amygdala damage alters the development of CRF and HPA axis systems, and that this brain region plays an inhibitory, rather than stimulatory, role early in life.
Although both groups showed the adult pattern of cortisol decline between early morning, afternoon, and night previously reported in juveniles (Sánchez et al., 2005; Goncharova et al., 2006; Barrett et al., 2009; Collura et al., 2009; Arce et al., 2010) , with no effects of Neo-A lesions on daytime cortisol slope, lesioned animals showed elevated cortisol secretions across all time points as compared with controls. Contrary to literature supporting the amygdala's stimulatory role on HPA axis activity (Norman and Spies, 1981; Sapolsky et al., 1991; Kalin et al., 2004; Machado and Bachevalier, 2008 ), our findings demonstrate that disruption of the amygdalar inputs to the hypothalamus and other structures regulating the HPA axis during primate neonatal development had a long-term stimulatory effect on basal HPA axis function. Our findings are consistent with recent reports that either CRF knockdown in the CeA or GR knock-out in the BLA result in elevated basal corticosterone secretion (Furay et al., 2008; Regev et al., 2012) . Thus, the amygdala could have an inhibitory influence on basal HPA axis activity in both primates and rodents during development, switching later on (in adolescence/adulthood) to be stimulatory. Our findings support an emerging literature on developmental switches of the amygdala's role regulating stress and fear responses. Rodent studies show that the amygdala is functionally dormant before weaning, when the pups are most dependent on maternal care, which is thought to inhibit fear responses toward the mother. This is followed by activation of the amygdala fear/defensive responses coinciding with rising corticosterone levels during the developmental transition to pup independence (after PND 16; Rincó n-Cortés and Sullivan, 2014) . Developmental switches have also been reported in humans, where amygdala functional connectivity with the medial prefrontal cortex switches from positive coupling during early childhood to negative (adult-like) coupling during the transition to adolescence (Gee et al., 2013b) . Interestingly, the functional relevance of this developmental switch from positive to negative coupling has been linked to a transition to stronger emotional regulation. Our findings are consistent with these reports indicating developmental switches in the amygdala's role in emotional and stress regulation.
Early life stress, including adverse caregiving experiences, leads to alterations in HPA axis function (Nemeroff et al., 1984; Sanchez, 2006; Hostinar and Gunnar, 2013) . Our findings provide a potential neurobiological mechanism explaining reports of blunted daytime cortisol secretion (Gunnar and Quevedo, 2008) , but higher amygdala volumes and activation/reactivity (Tottenham et al., 2010 Gee et al., 2013a) in some children with early adverse experience. Nonetheless, given that alterations in maternal care have a negative impact on HPA axis development, it remains possible that the elevated cortisol detected in Neo-A juvenile monkeys resulted from alterations in the mother-infant relationship. This seems unlikely given that neither infant attachment to the mother, nor mother-infant interactions were altered in the Neo-A animals (Goursaud et al., 2014; Raper et al., 2014) .
To examine the mechanisms underlying the increased HPA basal activity and stress reactivity (Raper et al., 2013b) detected in Neo-A prepubertal juveniles, we measured central CRF levels and used pharmacological challenges to assess pituitary-adrenal function and glucocorticoid negative feedback. Neo-A lesions did not affect cortisol responses to ACTH intravenous administration, suggesting that the differences in basal and stress-induced cortisol secretion are not due to alterations in adrenal cortex responsiveness to ACTH. Animals of both sexes reacted similarly to the ACTH challenge, consistent with reports that sex differences in response to ACTH do not emerge until puberty, when gonadal hormones rise (Meyer and Bowman, 1972; Wilson et al., 2005) .
Pituitary-adrenal functioning was further examined by measuring cortisol responses to CRF intravenous injection, which were blunted in Neo-A animals compared with controls. Although this blunted response could be due to an inability to increase cortisol secretion above the already high basal levels, such a potential ceiling effect is unlikely, given that Neo-A animals showed robust cortisol increases in response to stress at the same time of day and age (Raper et al., 2013b) . Rather, the blunted cortisol response to CRF suggests downregulation of pituitary CRF receptors in amygdalectomized animals, commonly interpreted as an adaptation to hypersecretion of hypothalamic CRF (Wynn et al., 1985; Hauger and Aguilera, 1993; De Bellis et al., 1994; Heim et al., 2001 ). This interpretation is supported, at least in Neo-A females, by the elevated CSF CRF levels found in lesioned animals. It is puzzling that Neo-A males did not show elevated CRF levels, despite similar blunted cortisol responses to CRF and increased basal cortisol secretion to Neo-A females. This sex difference in central CRF effects may reflect a long-term physiological adaptation in males, but not females (Heuser et al., 1994; Stroud et al., 2011) or a sexdependent effect of Neo-A damage; future studies need to elucidate these possibilities.
Elevated central CRF levels have been linked to anxiety and emotional dysregulation (Heinrichs and Koob, 2004) , with CeA CRF knockdown decreasing and CRF overexpression increasing anxiety-like behavior in rodents (Flandreau et al., 2012; Regev et al., 2012) . In monkeys, high CSF CRF levels are also associated with fearful temperament and stressful experiences (Kalin et al., 1983 (Kalin et al., , 2000 Strome et al., 2002; Broadbear, 2006) . In this study, although Neo-A animals had elevated CRF levels, they did not exhibit higher emotional reactivity (i.e., freezing, anxiety, or hostility) than controls during a separate study performed at the same age (Raper et al., 2013b) . Interestingly, although CSF CRF levels can reflect extrahypothalamic origin, several studies have also demonstrated a link between CSF CRF levels and cortisol levels in blood (Coplan et al., 1996 (Coplan et al., , 2001 Kalin et al., 2004) , suggesting a relationship between CSF CRF and HPA function. The significant association found in the current study between CSF CRF levels and the cortisol response to CRF administration provides further support for this link. Therefore, these data suggest that early amygdala damage causes long-term changes in the development of CRF systems, resulting in CRF overactivity and higher HPA axis activity.
Glucocorticoid negative feedback was assessed with the dexamethasone suppression test, with both groups showing cortisol suppression 10 h after dexamethasone administration in both sexes. The lack of sex difference is likely due to the developmental stage of the animals (juveniles in gonadal quiescence), because sex differences in dexamethasone suppression are influenced by estrogen levels (Heuser et al., 1994; Wilson et al., 2005) . The ability of amygdalectomized animals to suppress the morning rise in cortisol in response to dexamethasone indicates that these animals have functional GRs mediating glucocorticoid negative feedback. However, their cortisol escape from dexamethasone suppression later in the day (afternoon) was blunted compared with controls. This dexamethasone super-suppression suggests an increased functionality of GRs in regions that mediate glucocorticoid negative feedback, such as the PFC, hippocampus, or pituitary Myers et al., 2012) . These effects of amygdalectomy could be explained by increased GR expression/affinity or altered interactions with chaperone proteins regulated by cortisol (e.g., FKPBP5; Binder, 2009) or other cotransregulators. Although this has been previously reported in clinical conditions that exhibit dexamethasone supersuppression, such as PTSD (Yehuda et al., 2002; van Zuiden et al., 2011) , they report hypo-, and not hyper-cortisolemia, making it difficult to fully explain our findings. It is also possible that the changes in glucocorticoid negative feedback reflect direct effects of the lesions on amygdala GRs, whose activation by glucocorticoids, such as dexamethasone have a stimulatory, instead of inhibitory, effect on the HPA axis (Myers et al., 2012) . Although many studies underscore the importance of GRs in the hippocampus and PFC in inhibiting the HPA axis (Diorio et al., 1993; Boyle et al., 2005) , there is also strong evidence suggesting that amygdaloid GRs can stimulate the HPA axis (Beaulieu et al., 1986 (Beaulieu et al., , 1987 Shepard et al., 2003; Myers and Greenwood-Van Meerveld, 2011) . Therefore, control animals may show escape from dexamethasone suppression through a balance between GRs inhibitory effects and amygdaloid GR activation of the HPA axis, leading to a midday rise in cortisol, whereas amygdalectomized animals that lack amygdaloid GRs show impaired escape.
The amygdala is extensively connected to other brain regions critically involved in the regulation of the HPA axis and central CRF systems, such as the hippocampus and PFC (Aggleton, 2000) . These areas are not only rich in GRs but also exhibit a protracted development, like the amygdala (Diorio et al., 1993; Boyle et al., 2005; Payne et al., 2010). Thus, it is possible that early amygdala damage indirectly impacts the HPA axis and CRF systems by altering the development of the hippocampus and PFC. For example, as reviewed above amygdala-PFC connections are immature during early postnatal development, such that children exhibit a positive coupling between those regions that switches to negative coupling during adolescence (Gee et al., 2013b; , which influences basal cortisol levels (Urry et al., 2006; Veer et al., 2012) . Therefore, HPA axis and CRF alterations in Neo-A animals could result from disrupting the normal developmental pattern of amygdala-PFC connectivity, among other possibilities.
Contrary to the expected stimulatory effects of the amygdala based on adult studies, neonatal amygdalectomy resulted in elevated basal cortisol secretion during infancy and the juvenile period, and increased cortisol stress elevations, central CRF levels, and glucocorticoid negative feedback. These findings are of clinical relevance for neuropsychiatric disorders associated with aberrant amygdala development and HPA axis dysregulation, such as Autism spectrum disorder, schizophrenia, and affective disorders (Kaufman et al., 2001; Walker et al., 2008; Corbett et al., 2009; Schumann et al., 2011) , and suggest that early amygdala damage alters the development of central CRF and HPA systems resulting in longterm hyperactivity. Our findings represent only the impact of Neo-A lesions during the juvenile prepubertal stage. Additional investigations are underway to determine further changes as the animals reach adolescence and adulthood. Last, future studies will examine whether neonatal lesions impacted other systems, including the hypothalamic-pituitary-gonadal axis, pubertal timing, or metabolism. 
